PCT/1998/43 - World Intellectual Property Organization

43/1998
14944 PCT Gazette - Section I - Gazette du PCT 29 Oct/oct 1998
(54) •
•
METHOD FOR THE TREATMENT OF
STROKE USING N–HETEROCYCLIC
GLYOXYLAMIDE COMPOUNDS
PROCEDE DE TRAITEMENT D’ACCIDENT
CEREBROVASCULAIRE A L’AIDE DE
COMPOSES DE GLYOXYLAMIDE N–
HETEROCYCLIQUES
(71) SHIONOGI & CO., LTD. [JP/JP]; 1–8, Doshomachi
3–chome, Chuo–ku, Osaka–shi, Osaka
541–0045 (JP).
(for all designated States except / pour tous les États
désignés sauf US)
(72, 75) GEMBA, Takefumi [JP/JP]; 2–11–7, Obe, Kawanishi–shi,
Hyogo 666–0014 (JP). HORI, Yozo
[JP/JP]; 7–4–29, Nagaomotomachi, Hirakata–shi,
Osaka 573–0163 (JP).
(74) YAMAUCHI, Hideaki; 12–4, Sagisu 5–chome,
Fukushima–ku, Osaka–shi, Osaka 553–0002 (JP).
(81) AL AM AT AU AZ BA BB BG BR BY CA CH
CN CU CZ DE DK EE ES FI GB GE GH GM
GW HU ID IL IS JP KE KG KR KZ LC LK LR
LS LT LU LV MD MG MK MN MW MX NO NZ
PL PT RO RU SD SE SG SI SK SL TJ TM TR
TT UA UG US UZ VN YU ZW; AP (GH GM KE
LS MW SD SZ UG ZW); EA (AM AZ BY KG
KZ MD RU TJ TM); EP (AT BE CH CY DE DK
ES FI FR GB GR IE IT LU MC NL PT SE); OA
(BF BJ CF CG CI CM GA GN ML MR NE SN
TD TG).
(11) WO 98/47509 (13) A1
(21) PCT/US98/07318
(22) 16 Apr/avr 1998 (16.04.1998)
(25) en (26) en
(31) 60/044,626 (32) 18 Apr/avr 1997
(18.04.1997)
(43) 29 Oct/oct 1998 (29.10.1998)
(33) US
(51) 6 A61K 31/415, 31/635, 31/10, 31/18, 31/425,
31/44, 31/42, 31/38, 31/35, 31/535, 31/54, 31/00,
31/435
(54) • METHOD OF USING CYCLOOXYGENASE–
2 INHIBITORS IN THE PREVENTION OF
CARDIOVASCULAR DISORDERS
• PROCEDE RELATIF A L’UTILISATION
D’INHIBITEURS DE CYCLOOXYGENASE–2
DANS LA PREVENTION DES MALADIES
CARDIOVASCULAIRES
(71) G.D. SEARLE & CO. [US/US]; P.O. Box 5110,
Chicago, IL 60680 (US).
(for all designated States except / pour tous les États
désignés sauf US)
(72, 75) RONIKER, Barbara [US/US]; 1530 N.
Dearborn Parkway, Chicago, IL 60610 (US). La-
CHAPELLE, Richard, J. [US/US]; 1618 Central
Avenue, Wilmette, IL 60091 (US). CONNOLLY,
Daniel, T. [US/US]; 878 Mallard Woods Drive,
Ballwin, MO 63021 (US). SEIBERT, Karen
[US/US]; 11930 Greenwalk Drive, St. Louis, MO
63146 (US). NEEDLEMAN, Philip [US/US]; 326
New Salem Drive, Creve Coeur, MO 63146 (US).
(74) BULOCK, Joseph, W. et al. / etc.; G.D. Searle
& Co., Corporate Patent Dept., P.O. Box 5110,
Chicago, IL 60680–5110 (US).
(81) AL AM AT AU AZ BA BB BG BR BY CA CH
CN CU CZ DE DK EE ES FI GB GE GH GM GW
HU ID IL IS JP KE KG KP KR KZ LC LK LR
LS LT LU LV MD MG MK MN MW MX NO NZ
PL PT RO RU SD SE SG SI SK SL TJ TM TR
TT UA UG US UZ VN YU ZW; AP (GH GM KE
LS MW SD SZ UG ZW); EA (AM AZ BY KG
KZ MD RU TJ TM); EP (AT BE CH CY DE DK
ES FI FR GB GR IE IT LU MC NL PT SE); OA
(BF BJ CF CG CI CM GA GN ML MR NE SN
TD TG).
Published / Publiée : (c)
(11) WO 98/47510 (13) A1
(21) PCT/JP98/01918
(22) 24 Apr/avr 1998 (24.04.1998)
(25) ja (26) ja
(31) 9/107850 (32) 24 Apr/avr 1997 (33) JP
(24.04.1997)
(43) 29 Oct/oct 1998 (29.10.1998)
(51) 6 A61K 31/445, 45/00, 9/08
(54) • EYE DROPS
• COLLYRE
(71) TAISHO PHARMACEUTICAL CO., LTD.
[JP/JP]; 24–1, Takata 3–chome, Toshima–ku,
Tokyo 170–8633 (JP).
(for all designated States except / pour tous les États
désignés sauf US)
(72, 75) OKUDAIRA, Ichiro [JP/JP]; Taisho Pharmaceutical
Co., Ltd., 24–1, Takata 3–chome,
Toshima–ku, Tokyo 170–8633 (JP). TSUNODA,
Kenji [JP/JP]; Taisho Pharmaceutical Co., Ltd.,
24–1, Takata 3–chome, Toshima–ku, Tokyo
170–8633 (JP).
(74) KITAGAWA, Tomizo; Taisho Pharmaceutical Co.,
Ltd., Patent Division, 24–1, Takata 3–chome, Toshima–ku,
Tokyo 170–8633 (JP).
(81) AU CA CN KR US; EP (AT BE CH CY DE DK
ES FI FR GB GR IE IT LU MC NL PT SE).
(11) WO 98/47511 (13) A1
(21) PCT/FR98/00765
(22) 16 Apr/avr 1998 (16.04.1998)
(25) fr (26) fr
(31) 97/04801 (32) 17 Apr/avr 1997
(17.04.1997)
(33) FR
(43) 29 Oct/oct 1998 (29.10.1998)
(51) 6 A61K 31/505
(54) • USE OF MIZOLASTINE FOR PREPARING
A MEDICINE FOR TREATING INFLAMMA-
TION
• UTILISATION DE LA MIZOLASTINE
POUR LA PREPARATION D’UN MEDICA-
MENT DESTINE AU TRAITEMENT DE
L’INFLAMMATION
(71) SYNTHELABO [FR/FR]; 22, avenue Galilée,
F–92350 Le Plessis Robinson (FR).
(for all designated States except / pour tous les États
désignés sauf US)
(72, 75) ANGEL, Itzchak [IL/IL]; Lotus Street 22,
Nes–Ziyyona (IL). ARBILLA, Sonia [FR/FR]; 16,
rue J.M. de Hérédia, F–75007 Paris (FR). EVEN,
Luc [FR/FR]; 77, rue Lecourbe, F–75015 Paris
(FR). GOLDHILL, Jon [FR/FR]; 24, rue Champ
de Mars, F–75007 Paris (FR). PICHAT, Philippe
[FR/FR]; 28, rue de Chartres, F–91400 Orsay (FR).
(74) THOURET–LEMAITRE, Elisabeth; Synthélabo,
22, avenue Galilée, F–92350 Le Plessis Robinson
(FR).
(81) AL AM AT AU AZ BA BB BG BR BY CA CH
CN CU CZ DE DK EE ES FI GB GE GH GM GW
HU ID IL IS JP KE KG KP KR KZ LC LK LR
LS LT LU LV MD MG MK MN MW MX NO NZ
PL PT RO RU SD SE SG SI SK SL TJ TM TR
TT UA UG US UZ VN YU ZW; AP (GH GM KE
LS MW SD SZ UG ZW); EA (AM AZ BY KG
KZ MD RU TJ TM); EP (AT BE CH CY DE DK
ES FI FR GB GR IE IT LU MC NL PT SE); OA
(BF BJ CF CG CI CM GA GN ML MR NE SN
TD TG).
Published / Publiée : (c)
(11) WO 98/47512
(21) PCT/US98/07391
(13) A1
(22) 14 Apr/avr 1998 (14.04.1998)
(25) en (26) en
(31) 08/837,637 (32) 21 Apr/avr 1997
(21.04.1997)
(33) US
(43) 29 Oct/oct 1998 (29.10.1998)
(51) 6 A61K 31/53
(54) • 1,2,4–BENZOTRIAZINE OXIDES FORMU-
LATIONS
• FORMULATIONS OXYDES DE 1,2,4–
BENZOTRIAZINE
(71) SANOFI
[US/US];
PHARMACEUTICALS, INC.
90 Park Avenue, New York, NY
10016 (US).
(72) BROWN, Stephen; 17 The Croft, Ulgham, Morpeth,
Northumberland NE61 3BB (GB). BAKER,
Edward; 3 Bradshawgate, North Farm, Swinhoe,
Chathill, Northumberland NE67 5AA (GB).
(74) ALEXANDER, Michael, D.; Sanofi Pharmaceuticals,
Inc., Patent Dept., 9 Great Valley Parkway,
P.O. Box 3026, Malvern, PA 19355 (US).
(81) AL AU BA BB BG BR CA CN CU CZ EE GE
GW HU ID IL IS JP KP KR LC LK LR LT LV
MG MK MN MX NO NZ PL RO SG SI SK SL
TR TT UA UZ VN YU; AP (GH GM KE LS MW
SD SZ UG ZW); EA (AM AZ BY KG KZ MD
RU TJ TM); EP (AT BE CH CY DE DK ES FI FR
GB GR IE IT LU MC NL PT SE); OA (BF BJ CF
CG CI CM GA GN ML MR NE SN TD TG).
(11) WO 98/47513 (13) A1
(21) PCT/GB98/01161
(22) 22 Apr/avr 1998 (22.04.1998)
(25) en (26) en
(31) 9708289.5 (32) 24 Apr/avr 1997 (33) GB
(24.04.1997)
(31) 9721265.8 (32) 7 Oct/oct 1997 (33) GB
(07.10.1997)
(43) 29 Oct/oct 1998 (29.10.1998)
(51) 6 A61K 31/535, 31/675, 31/435, 31/445, 31/40,
31/47
(54) • USE OF NK–1 RECEPTOR ANTAGONISTS
FOR TREATING EATING DISORDERS
• UTILISATION DES ANTAGONISTES DU RE-
CEPTEUR DE NK–1 DANS LE TRAITEMENT
DES TROUBLES ALIMENTAIRES
(71) MERCK SHARP & DOHME LIMITED
[GB/GB]; Hertford Road, Hoddesdon, Hertfordshire
EN11 9BU (GB).
(for all designated States except / pour tous les États
désignés sauf US)
(72, 75) HEFTI, Franz, F. [US/GB]; Terlings Park,
Eastwick Road, Harlow, Essex CM20 2QR (GB).
(74) HISCOCK, Ian; Merck & Co., Inc., European Patent
Dept., Terlings Park, Eastwick Road, Harlow,
Essex CM20 2QR (GB).
(81) AL AM AT AU AZ BA BB BG BR BY CA CH
CN CU CZ DE DK EE ES FI GB GE GH GM GW
HU ID IL IS JP KE KG KP KR KZ LC LK LR
LS LT LU LV MD MG MK MN MW MX NO NZ
PL PT RO RU SD SE SG SI SK SL TJ TM TR
TT UA UG US UZ VN YU ZW; AP (GH GM KE
LS MW SD SZ UG ZW); EA (AM AZ BY KG
KZ MD RU TJ TM); EP (AT BE CH CY DE DK
ES FI FR GB GR IE IT LU MC NL PT SE); OA
(BF BJ CF CG CI CM GA GN ML MR NE SN
TD TG).
Published / Publiée : (c)